3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Neurofibromatosis 1
12
Neurofibroma, Plexiform
6
Carcinoma, Non-Small-Cell Lung
4
Neurofibrosarcoma
3
Neoplasms
3
Lung Neoplasms
3
Melanoma
2
Breast Neoplasms
2
Triple Negative Breast Neoplasms
1
Sarcoma
1
Recurrence
1
Primary Myelofibrosis
1
Pancreatic Neoplasms
1
Pain
1
Neoplasm Metastasis
1
Muscle Invasive Bladder Cancer
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Kidney Neoplasms
1
Gallbladder Neoplasms
1
Colonic Neoplasms
1
Carcinoma, Squamous Cell
1
Astrocytoma
1
Advanced Non Small Cell Lung Cancer
1
Adenocarcinoma
1
Interventions
pembrolizumab
119
Cisplatin
33
lenvatinib
29
Carboplatin
28
Paclitaxel
27
Docetaxel
14
Pemetrexed
13
Fluorouracil
12
Capecitabine
11
Saline Solution
10
Oxaliplatin
10
Gemcitabine
10
Albumin-Bound Paclitaxel
7
olaparib
6
Leucovorin
6
Bevacizumab
6
epacadostat
5
belzutifan
5
Etoposide
5
Cetuximab
5
130-nm albumin-bound paclitaxel
5
trifluridine tipiracil drug combination
3
regorafenib
3
patritumab deruxtecan
3
enzalutamide
3
enfortumab vedotin
3
durvalumab
3
Surgical Procedures, Operative
3
Radiotherapy
3
Levoleucovorin
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Parkinson Disease 4, Autosomal Dominant Lewy Body
×
AZD 6244
×
1 year
×
Clear all
No trials found.